Respiratory Depression

Oliceridine Granted Breakthrough Tx Status for Acute Pain

By February 22, 2016

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to intravenous oliceridine (TRV130) for the management of moderate-to-severe acute pain.